Absci (ABSI) Assets Average (2021 - 2026)
Absci (ABSI) reported Assets Average of $205.9 million for Q1 2026, down 7.66% on a YoY basis from $223.0 million in Q1 2025, and down 10.71% sequentially from $230.6 million in Q4 2025.
Absci (ABSI) Assets Average (2021 - 2026) Analysis & Trends
Absci (ABSI) has 6 years of Assets Average data on file, last reported at $205.9 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 7.66% year-over-year to $205.9 million; the trailing twelve-month figure through Mar 2026 stood at $205.9 million (down 7.66% YoY), and the FY2025 full-year result was $215.0 million, changed 0.23% from the prior year.
- Assets Average retreated to $205.9 million in Q1 2026, from $230.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $410.8 million in Q1 2022 to a low of $205.9 million in Q1 2026.
- A 5-year average of $271.7 million and a median of $245.4 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average slumped 31.31% in 2023 and advanced 2.77% in 2025, its largest moves.
- Tracing ABSI's Assets Average over 5 years: stood at $330.2 million in 2022, then tumbled by 31.31% to $226.8 million in 2023, then retreated by 1.06% to $224.4 million in 2024, then grew by 2.77% to $230.6 million in 2025, then dropped by 10.71% to $205.9 million in 2026.
- Business Quant data shows ABSI's Assets Average at $205.9 million in Q1 2026, $230.6 million in Q4 2025, and $227.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 205.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205.95 Mn |
| Dec 31, 2025 | 230.64 Mn |
| Sep 30, 2025 | 227.44 Mn |
| Jun 30, 2025 | 221.17 Mn |
| Mar 31, 2025 | 223.03 Mn |
| Dec 31, 2024 | 224.42 Mn |
| Sep 30, 2024 | 245.38 Mn |
| Jun 30, 2024 | 265.21 Mn |
| Mar 31, 2024 | 246.10 Mn |
| Dec 31, 2023 | 226.82 Mn |
| Sep 30, 2023 | 245.25 Mn |
| Jun 30, 2023 | 274.98 Mn |
| Mar 31, 2023 | 308.41 Mn |
| Dec 31, 2022 | 330.20 Mn |
| Sep 30, 2022 | 352.85 Mn |
| Jun 30, 2022 | 380.89 Mn |
| Mar 31, 2022 | 410.83 Mn |
| Dec 31, 2021 | 437.66 Mn |
| Sep 30, 2021 | 353.09 Mn |